Satter Muneer A 13D/13G Filings for Aerpio Pharmaceuticals, Inc. (ARPO)

Satter Muneer A 13D and 13G filings for Aerpio Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2020-11-20
5:31 pm
Unchanged		2020-11-1013DAerpio Pharmaceuticals, Inc.
ARPO		Satter Muneer A374,789
11.900%		0
(Unchanged)		Filing